FI65547C - Foerfarande foer framstaellning av foer inhalering avsedda mjuka dinatriumkromoglykatpelletar - Google Patents
Foerfarande foer framstaellning av foer inhalering avsedda mjuka dinatriumkromoglykatpelletar Download PDFInfo
- Publication number
- FI65547C FI65547C FI752232A FI752232A FI65547C FI 65547 C FI65547 C FI 65547C FI 752232 A FI752232 A FI 752232A FI 752232 A FI752232 A FI 752232A FI 65547 C FI65547 C FI 65547C
- Authority
- FI
- Finland
- Prior art keywords
- spheres
- soft
- particles
- drug
- weight
- Prior art date
Links
- 239000002245 particle Substances 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 20
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 229960000265 cromoglicic acid Drugs 0.000 claims description 15
- 238000002156 mixing Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 description 35
- 229940079593 drug Drugs 0.000 description 33
- 239000000843 powder Substances 0.000 description 24
- 239000002775 capsule Substances 0.000 description 21
- 238000012360 testing method Methods 0.000 description 8
- 238000005243 fluidization Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 6
- 238000005054 agglomeration Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000003801 milling Methods 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000005453 pelletization Methods 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- HQARDVLSJLCFBA-UHFFFAOYSA-N 4-[(4-aminophenyl)carbamoyl]-1h-imidazole-5-carboxylic acid Chemical compound C1=CC(N)=CC=C1NC(=O)C1=C(C(O)=O)NC=N1 HQARDVLSJLCFBA-UHFFFAOYSA-N 0.000 description 1
- QFLQVUAJKXUXOF-UHFFFAOYSA-N 7-[3-(2-carboxy-4-oxochromen-7-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylic acid Chemical compound O1C(C(O)=O)=CC(=O)C=2C1=CC(OCC(COC=1C=C3C(C(C=C(O3)C(O)=O)=O)=CC=1)O)=CC=2 QFLQVUAJKXUXOF-UHFFFAOYSA-N 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 208000035126 Facies Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241001234580 Palio Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- HGYBWKSFVPDKOX-UHFFFAOYSA-L disodium;7-[3-(2-carboxylato-4-oxochromen-7-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C=2C1=CC(OCC(COC=1C=C3C(C(C=C(O3)C([O-])=O)=O)=CC=1)O)=CC=2 HGYBWKSFVPDKOX-UHFFFAOYSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229960001317 isoprenaline Drugs 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000005029 sieve analysis Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Otolaryngology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3533474 | 1974-08-10 | ||
| GB35334/74A GB1520247A (en) | 1974-08-10 | 1974-08-10 | Pelletised medicament formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI752232A7 FI752232A7 (enrdf_load_stackoverflow) | 1976-02-11 |
| FI65547B FI65547B (fi) | 1984-02-29 |
| FI65547C true FI65547C (fi) | 1984-06-11 |
Family
ID=10376566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI752232A FI65547C (fi) | 1974-08-10 | 1975-08-06 | Foerfarande foer framstaellning av foer inhalering avsedda mjuka dinatriumkromoglykatpelletar |
Country Status (21)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2741202A1 (de) * | 1976-09-23 | 1978-03-30 | Fisons Ltd | Dinatriumcromoglycat mit besonderer massendichte |
| JPS6034925B2 (ja) * | 1979-07-31 | 1985-08-12 | 帝人株式会社 | 持続性鼻腔用製剤およびその製造法 |
| DE3636209A1 (de) * | 1986-10-24 | 1988-04-28 | Lentia Gmbh | Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates |
| GB8911259D0 (en) * | 1989-05-17 | 1989-07-05 | Fisons Plc | Inhalation medicament |
| US5198221A (en) * | 1989-05-17 | 1993-03-30 | Fisons Plc | Pharmaceutical composition |
| GB2237510B (en) * | 1989-11-04 | 1993-09-15 | Danbiosyst Uk | Small particle drug compositions for nasal administration |
| US6794357B1 (en) | 1993-06-24 | 2004-09-21 | Astrazeneca Ab | Compositions for inhalation |
| US6632456B1 (en) | 1993-06-24 | 2003-10-14 | Astrazeneca Ab | Compositions for inhalation |
| US5830853A (en) | 1994-06-23 | 1998-11-03 | Astra Aktiebolag | Systemic administration of a therapeutic preparation |
| IS1736B (is) | 1993-10-01 | 1999-12-30 | Astra Ab | Aðferð og tæki sem stuðla að aukinni samloðun agna |
| EP0721331B1 (en) * | 1993-10-01 | 2001-12-05 | AstraZeneca AB | Process i |
| US6102036A (en) * | 1994-04-12 | 2000-08-15 | Smoke-Stop | Breath activated inhaler |
| US6165976A (en) | 1994-06-23 | 2000-12-26 | Astra Aktiebolag | Therapeutic preparation for inhalation |
| DE4425255A1 (de) | 1994-07-16 | 1996-01-18 | Asta Medica Ag | Formulierung zur inhalativen Applikation |
| US6524557B1 (en) | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
| MX9704544A (es) | 1994-12-22 | 1997-10-31 | Astra Aktebolag | Preparacion terapeutica para inalacion que contiene hormona paratiroidea, pth. |
| HUT77775A (hu) | 1994-12-22 | 1998-08-28 | Astra Aktiebolag | Aeroszolformák |
| TWI225402B (en) | 1996-03-13 | 2004-12-21 | Biochemie Gmbh | Auxiliary-free agglomerates |
| US6503537B2 (en) | 1997-03-20 | 2003-01-07 | Schering Corporation | Preparation of powder agglomerates |
| DE69840277D1 (de) | 1997-03-20 | 2009-01-08 | Schering Corp | Dosierungsform eines Pulveragglomerates |
| US6495167B2 (en) | 1997-03-20 | 2002-12-17 | Schering Corporation | Preparation of powder agglomerates |
| US6623760B1 (en) | 1999-01-28 | 2003-09-23 | Schering Corporation | Method of preparing particles for agglomeration |
| ITMI991582A1 (it) | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala |
| PE20011227A1 (es) | 2000-04-17 | 2002-01-07 | Chiesi Farma Spa | Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros |
| GB0009469D0 (en) | 2000-04-17 | 2000-06-07 | Vectura Ltd | Improvements in or relating to formalities for use in inhaler devices |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1812574A1 (de) * | 1968-12-04 | 1970-06-11 | Riedel De Haen Ag | Verfahren zur Herstellung biozider Granulate |
| GB1381872A (en) * | 1971-06-22 | 1975-01-29 | Fisons Ltd | Pharmaceutical compositions for inhalation |
-
1974
- 1974-08-10 GB GB35334/74A patent/GB1520247A/en not_active Expired
-
1975
- 1975-07-23 ZA ZA00754765A patent/ZA754765B/xx unknown
- 1975-07-23 IE IE1645/75A patent/IE41586B1/en not_active IP Right Cessation
- 1975-07-24 CY CY1049A patent/CY1049A/xx unknown
- 1975-07-28 IL IL47829A patent/IL47829A/xx unknown
- 1975-07-29 CA CA232,477A patent/CA1072569A/en not_active Expired
- 1975-07-30 NL NLAANVRAGE7509080,A patent/NL177980C/xx not_active IP Right Cessation
- 1975-07-31 AR AR259849A patent/AR210997A1/es active
- 1975-08-04 BE BE158922A patent/BE832097A/xx not_active IP Right Cessation
- 1975-08-06 FI FI752232A patent/FI65547C/fi not_active IP Right Cessation
- 1975-08-07 BR BR7505055*A patent/BR7505055A/pt unknown
- 1975-08-07 FR FR7524631A patent/FR2282259A1/fr active Granted
- 1975-08-08 DK DK360875A patent/DK145654C/da not_active IP Right Cessation
- 1975-08-08 HU HU75FI596A patent/HU175594B/hu unknown
- 1975-08-08 LU LU73182A patent/LU73182A1/xx unknown
- 1975-08-08 NO NO752786A patent/NO146660C/no unknown
- 1975-08-08 SE SE7508967A patent/SE440595B/xx not_active IP Right Cessation
- 1975-08-11 JP JP50096732A patent/JPS5910326B2/ja not_active Expired
-
1980
- 1980-03-10 KE KE3034A patent/KE3034A/xx unknown
- 1980-04-03 HK HK177/80A patent/HK17780A/xx unknown
-
1981
- 1981-12-30 MY MY34/81A patent/MY8100034A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI65547C (fi) | Foerfarande foer framstaellning av foer inhalering avsedda mjuka dinatriumkromoglykatpelletar | |
| US4590206A (en) | Inhalation pharmaceuticals | |
| US4161516A (en) | Composition for treating airway disease | |
| US5260306A (en) | Inhalation pharmaceuticals | |
| GB2105189A (en) | Inhalation drugs | |
| Braun et al. | Influence of excipients and storage humidity on the deposition of disodium cromoglycate (DSCG) in the twin impinger | |
| Ghebre-Sellassie et al. | Evaluation of a high-speed pelletization process and equipment | |
| GB1569611A (en) | Pelletised or granular medicament formulation | |
| JPH06192113A (ja) | 生薬類の造粒方法および固形製剤 | |
| FI67663B (fi) | Foerfarande foer framstaellning av ihalerbara mjuka dinatriumkromoglykatgranulater | |
| CA1144862A (en) | Composition | |
| KR20190059308A (ko) | 구상(球狀)의 분말 응집체 및 그 제조 방법 | |
| JPH0142950B2 (enrdf_load_stackoverflow) | ||
| TWI642366B (zh) | 球狀之粉末凝聚體及其製造方法 | |
| GB1569612A (en) | Disodium cromoglycate pellets or granules | |
| Zhang et al. | Chitosan and β-cyclodextrin microspheres as pulmonary sustained delivery systems | |
| TWI636741B (zh) | 球狀之粉末凝聚體及其製造方法 | |
| IE45261B1 (en) | Disodium cromoglycate pellets or granules | |
| WO2002100378A2 (en) | Process for the preparation of a particulate material | |
| GB1569613A (en) | Disodium cromoglycate in a form |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MA | Patent expired | ||
| MA | Patent expired |
Owner name: FISONS LIMITED |